25 March 2026
Toray develops size-controlled PMMA porous fibers to selectively remove pathogenic proteins
PMMA porous fibers with controllable pores (several nm to ~1,000 nm) selectively capture high-MW pathogenic substances (autoantibodies, lipoproteins, exosomes), enabling blood purification and biopharma
